MetLife Investment Management Hires New Head of Real Estate, Agriculture From Blackstone
MetLife Investment Management has appointed Andrea Drasites as its new global head of real estate and agricultural finance, effective October 1. She will oversee $108.9 billion in assets and succeeds Robert Merck. Drasites joins MIM from Blackstone’s real estate group, where she served as a senior managing director for 13 years.
Globe Life Inc stock: Undervalued insurance play worth watching now
Globe Life Inc. is presented as an undervalued insurance company specializing in life and supplemental health products for underserved U.S. demographics. The article highlights its resilient business model, consistent earnings, and status as a stable, dividend-paying stock with low volatility, making it an attractive option for long-term, value-oriented investors seeking defensive growth. Despite some risks like debt levels and insider selling, analysts maintain a "Moderate Buy" rating, pointing to its fair value discount and steady performance.
Who's Moving Where In Wealth Management? – Aiviq, MetLife
Aiviq, a client data management platform, has appointed Nicholas Morse as head of revenue for the Americas to lead commercial strategy and growth. MetLife Investment Management has named Andrea Drasites as head of real estate and agricultural finance, succeeding Robert Merck. These appointments highlight significant personnel changes in the North American wealth management sector.
MetLife reports preliminary Q1 variable investment income of $475-$525 million By Investing.com
MetLife Inc. announced preliminary Q1 variable investment income of $475-$525 million before taxes for the quarter ended March 31, 2026, which includes income from private equity, real estate, and prepayment fees. The company's full-year 2026 guidance for variable investment income remains at about $1.6 billion before taxes. These unaudited estimates are based on current information, and final results will be released on May 6, 2026, alongside their full quarterly earnings report.
MetLife Inc estimates Q1 2026 variable investment income of $475 million-$525 million pre-tax - SEC filing
MetLife Inc. forecasts its Q1 2026 variable investment income to be between $475 million and $525 million on a pre-tax basis, according to a recent SEC filing. This estimate provides insight into the company's financial outlook for the upcoming quarter. The article also includes recent analyst rating adjustments and other company news.
Metlife Inc - Estimates Q1 2026 Variable Investment Income Of $475 Million-$525 Million Pre-Tax - SEC Filing
Metlife Inc. estimates its variable investment income for the first quarter of 2026 to be between $475 million and $525 million pre-tax. This information was released via an SEC filing and reported by Refinitiv. The article provides a brief update on the company's financial outlook.
MetLife Investment Management appoints Andrea Drasites to lead real estate and agricultural finance
MetLife Investment Management has appointed Andrea Drasites as the head of its real estate and agricultural finance division. In this role, Drasites will oversee lending and investment strategies for commercial real estate and agricultural assets, reflecting the firm's focus on strengthening leadership in these key investment segments. This move comes as institutional investors increasingly reallocate capital towards income-generating and inflation-hedged asset classes.
Principal Financial (NYSE: PFG) touts 18% TSR, $1.5B returns in proxy
Principal Financial Group (NYSE: PFG) highlights strong 2025 financial performance in its proxy statement, including an 18% total shareholder return that outperformed the S&P 500 and over $1.5 billion returned to shareholders through repurchases and dividends. The company reported $781 billion in assets under management and $1.8 trillion in assets under administration, with margins expanding to 31%. Shareholders are asked to vote on director elections, executive pay, auditor ratification, and a new stock incentive plan at the upcoming virtual annual meeting on May 19, 2026.
Personalized Insurance Policies Market Is Booming Worldwide | Major Giants Oscar Health, Lemonade Insurance Company
The global Personalized Insurance Policies Market is projected to grow at a CAGR of 8.20% from $6.1 billion in 2025 to $12.0 billion by 2033. This growth is driven by the increasing use of AI-driven personalization tools, integration with big data analytics, and a rising focus on customer-centric insurance models. The market is segmented by policy types such as AI-driven, behavior-based, and usage-based, and by applications including health, automotive, and life insurance, with Europe currently dominating and North America showing the fastest growth.
Reinsurance Group of America, Incorporated $RGA Shares Bought by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL significantly increased its stake in Reinsurance Group of America (NYSE: RGA) by 616.3% in Q3, now holding 60,870 shares valued at approximately $11.7 million. The insurance provider reported strong Q3 earnings, with an EPS of $7.75 and revenue up 26.6% year-over-year, surpassing analyst expectations. The company also announced a quarterly dividend of $0.93 per share, and analysts maintain a "Moderate Buy" rating with an average price target of $249.33.
Morgan Stanley Lowers Price Target on MetLife to $89 From $93, Keeps Overweight Rating
Morgan Stanley has adjusted its price target for MetLife (MET) to $89, down from the previous $93, while maintaining an "Overweight" rating on the stock. This update reflects a revised valuation perspective from the firm. The article also mentions recent MetLife developments including executive appointments and changes in S&P 100 listing.
MetLife 2023 Sustainability Report: Creating Value as an Investor
MetLife's 2023 Sustainability Report highlights its responsible investment strategy, managing over $420 billion in assets with a focus on long-term value and ESG factors. The company exceeded its 2030 DEI commitment by investing over $1.4 billion in diverse firms between 2021 and 2023. MetLife Investment Management has also integrated impact investing through its acquisition of Affirmative Investment Management, reinforcing its commitment to sustainability and financial stability.
Is MetLife (MET) one of the best insurance stocks to buy?
The article "Is MetLife (MET) one of the best insurance stocks to buy?" discusses MetLife (MET) as a potential investment in the insurance sector. It will likely delve into various factors that make the company an attractive or unattractive option for investors, possibly including its financial performance, market position, and future outlook.
SG Americas Securities LLC Boosts Holdings in Kemper Corporation $KMPR
SG Americas Securities LLC significantly increased its stake in Kemper Corporation (NYSE:KMPR) by 361% in the fourth quarter, now owning 78,507 shares valued at $3.18 million. Despite this, multiple research firms have downgraded Kemper, leading to a consensus "Reduce" rating and a target price of $56.50. The company recently missed earnings and revenue expectations, and its stock is trading near its 52-week low, while still offering a quarterly dividend with a 4.2% yield.
Aberdeen Group plc Acquires 39,512 Shares of MetLife, Inc. $MET
Aberdeen Group plc increased its holdings in MetLife, Inc. by 4.8% during the fourth quarter, purchasing an additional 39,512 shares and now owning 855,799 shares valued at approximately $67.56 million. MetLife reported strong Q4 results, surpassing earnings and revenue expectations, and offers a quarterly dividend of $0.5675. The company currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $93.42.
MetLife, Inc. Depositary Shs Repr 1/1000th 4.75 % Non-Cum Perp Red Pfd Shs Series F Trade Ideas — BOATS:MET/PF
This article compiles several trade ideas for MetLife, Inc. Depositary Shares (MET/PF) from various traders on TradingView. The ideas range from potential long positions based on technical analysis like double bottoms, Fibonacci retracements, and ascending triangles, to specific option strategies. Many analysts see potential for a bullish reversal or continued upside for MET/PF, citing strong technical indicators and breakout patterns.
MetLife (NYSE: MET) director receives 721-share stock grant
MetLife (NYSE: MET) director Michelle Seitz received a grant of 721 shares of common stock as part of her board compensation. These shares were awarded at $0.00 per share as a non-management director retainer and increased her direct holdings to 994 shares. This transaction was reported in a Form 4 filing and is consistent with MetLife's compensation arrangements for non-management directors.
MetLife (NYSE: MET) director receives 721 deferred stock shares
MetLife Inc. director Carla A. Harris was awarded 721 shares of common stock as part of her non-management director compensation. These shares, valued at $71.17 each, are being deferred under the MetLife Deferred Compensation Plan for Non-Management Directors. Following this grant, Carla A. Harris directly holds 10,485 shares of MetLife common stock.
MetLife (MET) director Laura J. Hay granted 721 deferred shares as board fees
MetLife director Laura J. Hay received a grant of 721 deferred shares of common stock as part of her non-management director compensation, valued at $71.17 per share. This is a routine, compensation-related award, not an open-market purchase, and increases her direct holdings to 5,692 shares. Hay elected to defer the receipt of these shares under MetLife's Deferred Compensation Plan for Non-Management Directors.
[Form 4] METLIFE INC Insider Trading Activity
MetLife Inc. director Denise M. Morrison reported the acquisition of 721 shares of MetLife common stock on April 1, 2026, as part of her non-management director compensation. These shares were granted at $0.00 per share, reflecting stock-based fees rather than a market purchase. Following this award, Morrison directly holds 34,711 shares of MetLife common stock, a transaction indicating routine equity compensation aligned with company policy.
MetLife (NYSE: MET) director granted 1,248 deferred shares as fees
MetLife Inc. director Robert Glenn Hubbard was granted 1,248 deferred shares of common stock, valued at $71.17 per share, as part of his non-management director compensation. These shares represent retainer fees paid in stock, which Hubbard elected to defer. Following this transaction, his direct holdings in MetLife common stock increased to 105,878 shares.
Director William Kennard receives 721-share stock grant at MetLife (NYSE: MET)
MetLife Inc. director William E. Kennard received a grant of 721 shares of MetLife common stock on April 1, 2026, as part of his non-management director compensation. The shares were valued at $71.17 each, and Kennard elected to defer their receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Following this award, Kennard beneficially owns 46,501 shares directly and an additional 10 shares indirectly through the MetLife Policyholder Trust.
MetLife, Inc. Depositary Shs Repr 1/1000th 4.75 % Non-Cum Perp Red Pfd Shs Series F Trade Ideas — BOATS:MET/PF
This article compiles various trade ideas and technical analyses for MetLife (MET/PF) from TradingView users. Traders present both bullish and bearish outlooks, discussing patterns like trendlines, moving averages, RSI, and MACD, alongside interpretations of earning reports and historical data. Many analysts focus on potential breakouts, support/resistance levels, and short-term price movements for the stock.
Is MetLife (MET) one of the best insurance stocks to buy?
The article poses a question about whether MetLife (MET) is one of the best insurance stocks to buy. Without additional content, a definitive answer or further details about MetLife's performance or market position cannot be provided.
Do MetLife’s AM Best Nod and New Policy Hires Refine Its Risk Story For MET Investors?
MetLife recently had its "Superior" financial strength and credit ratings affirmed by AM Best with a stable outlook, while also making key hires in federal government affairs and investment management. These developments highlight MetLife's focus on regulatory engagement and asset management, which are crucial for investors monitoring balance sheet quality and policy influence. The article suggests that while AM Best's affirmation reinforces MetLife's capital strength, investors should remain aware of potential commercial mortgage loan losses.
MetLife Investment Management Names New Head of Real Estate and Agricultural Finance
MetLife Investment Management has appointed Andrea Drasites as the new Head of Real Estate and Agricultural Finance, overseeing significant investment divisions. This move highlights MetLife's strategic focus on expanding its alternative investment capabilities in these growing sectors. Drasites will be responsible for leading strategy, portfolio management, and risk oversight to drive growth and manage risk within these key areas.
MetLife, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Market Metrics
MetLife, Inc. has recently adjusted its stock valuation, now reporting a P/E ratio of 20, a price-to-book value of 2.42, and an exceptionally high dividend yield of 248.42% with an ROE of 11.90%. The company's stock performance has been mixed, lagging the S&P 500 over the past year and three years despite showing resilience over the longer term. These metrics highlight MetLife's position within the competitive insurance sector compared to peers like Progressive Corp., The Travelers Companies, Inc., and Aflac, Inc.
Andrea Drasites Named Head of Real Estate and Agricultural Finance For Metlife
MetLife Investment Management (MIM) has announced Andrea Drasites will join as global head of Real Estate and Agricultural Finance, effective October 1, 2026. She will oversee the company's commercial mortgage, equity real estate, and agricultural investments portfolios, which amounted to $108.9 billion in assets under management as of December 31, 2025. Drasites brings extensive experience from Blackstone, where she was a senior managing director in the Real Estate Group.
MetLife Investment Management names new real estate head By Investing.com
MetLife Investment Management has announced the appointment of Andrea Drasites as its new global head of Real Estate and Agricultural Finance, effective October 1, 2026. Drasites, formerly of Blackstone, will oversee MIM's substantial real estate and agricultural assets, reporting to company president Brian Funk. This strategic leadership change follows MetLife's recent acquisition of PineBridge Investments and comes amid other key executive appointments and strong financial performance.
MetLife (NYSE: MET) files Form 144 listing affiliate Common Stock sales
MetLife (NYSE: MET) has filed a Form 144, indicating proposed sales of Common Stock by affiliated accounts. The filing details planned transactions and sales completed within the last three months, including share counts and dollar amounts for accounts like the MetLife 401k Plan Trust and Separate Account SPI. This is a routine regulatory notice providing transparency on affiliate stock dispositions.
MetLife Investment Management Names Andrea Drasites Head of Real Estate and Agricultural Finance
MetLife Investment Management (MIM) has announced the appointment of Andrea Drasites as its global head of Real Estate and Agricultural Finance, effective October 1, 2026. Drasites, joining from Blackstone, will be responsible for MIM’s commercial mortgage, equity real estate, and agricultural investment portfolios, which managed $108.9 billion in assets as of December 31, 2025. This appointment follows MIM's acquisition of PineBridge Investments in December 2025, which expanded its global footprint and increased its total assets under management to $741.7 billion.
MetLife Investment Management Names Andrea Drasites Head of Real Estate and Agricultural Finance
MetLife Investment Management (MIM) has appointed Andrea Drasites as its global head of Real Estate and Agricultural Finance, effective October 1, 2026. Drasites, formerly with Blackstone, will oversee MIM's commercial mortgage and equity real estate portfolios, as well as its agricultural investments, which collectively totaled $108.7 billion in gross assets under management as of December 31, 2025. This move aims to accelerate growth and scale MIM's global capabilities following its acquisition of PineBridge Investments in December 2025.
MetLife Investment Management Names Andrea Drasites Head of Real Estate and Agricultural Finance
MetLife Investment Management (MIM) has appointed Andrea Drasites as the new global head of Real Estate and Agricultural Finance, effective October 1, 2026. Drasites, formerly of Blackstone, will oversee MIM's substantial commercial mortgage, equity real estate, and agricultural investments portfolios, which totaled $108.9 billion in gross assets as of December 31, 2025. Her appointment follows MIM's recent acquisition of PineBridge Investments, enhancing its position as a diversified global asset manager.
MetLife Investment Management Names Andrea Drasites Head of Real Estate and Agricultural Finance
MetLife Investment Management (MIM) has announced the appointment of Andrea Drasites as the global head of Real Estate and Agricultural Finance, effective October 1, 2026. Drasites, who previously held leadership positions at Blackstone, will lead MIM's commercial mortgage and equity real estate portfolios, as well as its agricultural investments, which amounted to $108.7 billion in gross real estate and agricultural assets under management as of December 31, 2025. Her appointment follows the retirement of Robert Merck and aims to accelerate growth and scale MIM's global capabilities after the acquisition of PineBridge Investments.
MetLife Investment Management Names Andrea Drasites Head of Real Estate and Agricultural Finance
MetLife Investment Management (MIM) has appointed Andrea Drasites as the new global head of Real Estate and Agricultural Finance, effective October 1, 2026. Drasites, formerly a senior managing director at Blackstone, will lead MIM's commercial mortgage, equity real estate, and agricultural investment portfolios, which managed $108.9 billion in gross assets as of December 31, 2025. Her appointment follows MIM's acquisition of PineBridge Investments, which has expanded its total assets under management to $741.7 billion.
MetLife Inc. stock: Stable insurance giant with strong analyst upside potential amid sector recovery
MetLife Inc. (NYSE: MET) is presented as a resilient choice for North American investors in the life insurance and annuities sector, offering a moderate buy consensus and over 20% upside potential. The company's diversified operations across various segments and geographies, coupled with strong financial health and strategic initiatives, position it well for growth. Investors are advised to monitor interest rate fluctuations, regulatory changes, and competitive pressures, while benefiting from the stock's defensive qualities and income generation.
Prudential Leadership Shift Sparks Governance Questions For Long Term Investors
Prudential Financial, Inc. has appointed Andrew Sullivan as Chairman, a transition occurring as the company is urging shareholders to vote against a proposal to separate the Chairman and CEO roles. This leadership change and the board's stance on governance raise questions for long-term investors concerning accountability, risk management, and capital allocation, especially given Prudential's significant balance sheet and long-term commitments. The situation presents both risks, like concentrated power and potential shareholder friction, and rewards, such as leadership continuity and added macroeconomic expertise.
Prudential Financial Stock: A Comprehensive Look at Business Model, Market Position, and Investor Co
This article provides a comprehensive analysis of Prudential Financial (PRU), a major player in the U.S. insurance and financial services sector. It delves into the company's core business model, market position, competitive strengths, and risks for North American investors. The analysis highlights Prudential's diversified operations across PGIM, U.S. Businesses, and International Businesses, its resilience in a dynamic financial landscape, and key factors for investors to monitor.
TIPT SEC Filings - Tiptree Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive overview of Tiptree Inc. (TIPT) SEC filings, including 10-K, 10-Q, 8-K, and insider trading forms, offering investors direct access to regulatory disclosures. It details recent material events such as the sale of Reliance First Capital, plans for the Fortegra Group acquisition by DB Insurance Co., Ltd., and dividend declarations. AI-powered summaries and impact analyses are available for each filing to help investors understand Tiptree's financial health, capital allocation, and strategic decisions.
PGIM Global Total Return (USD Hedged) Fund's MetLife Inc(MET) Holding History
This article details the MetLife Inc (MET) holding history for the PGIM Global Total Return (USD Hedged) Fund. As of January 31, 2026, the fund held 541 shares of MET, valued at $13,030, representing 8.01% of its stock portfolio. The fund has an estimated loss of -9.81% on its MET holdings based on the current price.
AM Best Affirms Credit Ratings of MetLife, Inc. and Its Life/Health Subsidiaries
AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Ratings of "aa-" (Superior) for MetLife and its life/health subsidiaries. These ratings, which have a stable outlook, reflect MetLife's strong balance sheet, operating performance, very favorable business profile, and appropriate enterprise risk management. The details of various affirmed Long-Term Issue Credit Ratings for MetLife, Inc. are also outlined.
Fortune Media Recognizes MetLife as a ‘Fortune 100 Best Companies to Work For’ for Fourth Consecutive Year
MetLife has been recognized by Fortune Media as one of the ‘Fortune 100 Best Companies to Work For’ for the fourth consecutive year, based on positive employee feedback from Great Place to Work’s Trust Index™ Survey. This recognition highlights MetLife's strong workplace culture, characterized by high trust, purpose, and collaboration, and is further supported by global accolades including ranking among Fortune World's 25 Best Workplaces. Company executives emphasize that empowering employees leads to innovation, better customer outcomes, and sustainable business results.
90% of MetLife employees express pride as Fortune honors workplace
MetLife (NYSE: MET) has been recognized as one of the Fortune 100 Best Companies to Work For® in the U.S. for the fourth consecutive year, based on employee feedback indicating a high-trust, high-performance culture. The recognition highlights that 90% of employees express pride in the company and 87% consider it a great place to work. In addition to its U.S. recognition, MetLife also ranked No. 10 on the Fortune World's 25 Best Workplaces™ list in 2025 and has been certified as a Great Place to Work in 33 markets globally.
Brighthouse Financial (NASDAQ:BHF) Rating Lowered to "Strong Sell" at Zacks Research
Zacks Research has downgraded Brighthouse Financial (NASDAQ:BHF) from a "hold" to a "strong sell" rating. This downgrade aligns with a mixed analyst consensus, with MarketBeat showing an average rating of "Reduce" and a target price of $60.86. The article also details recent stock performance, institutional investor activity, and highlights Brighthouse Financial's business as a U.S.-based life insurance company specializing in retirement income solutions.
MetLife Names Jordan Canter Head of Federal Government Affairs and Regulatory Policy
MetLife, Inc. (NYSE: MET) has announced the appointment of Jordan Canter as the new head of Federal Government Affairs and Regulatory Policy, effective April 20. She will be responsible for overseeing MetLife’s federal government affairs and global regulatory policy efforts, working with stakeholders to support the company’s business objectives. Canter brings extensive experience from previous senior roles at Allstate, The Hartford, and the Bank Policy Institute.
MetLife Inc. stock outperforms competitors on strong trading day
MetLife Inc. (MET) stock increased by 3.59% to $70.72, outperforming its competitors and the broader market on a strong trading day. The S&P 500 Index and Dow Jones Industrial Average also saw significant gains. This marks the second consecutive day of gains for MetLife's stock.
Viridian Therapeutics (NASDAQ:VRDN) Given New $37.00 Price Target at Wedbush
Wedbush has lowered its price target for Viridian Therapeutics (NASDAQ:VRDN) to $37.00 from $44.00, while maintaining an "outperform" rating, suggesting a significant upside. This adjustment comes despite the company's Phase 3 REVEAL‑1 trial for elegrobart meeting its primary endpoint, as the stock experienced a sharp intraday drop and an earnings per share miss. Viridian Therapeutics continues to hold a "Moderate Buy" consensus rating among analysts with an average target of $39.50.
ORI Outperforms Industry, Trades at a Discount: How to Play the Stock
Old Republic International Corporation (ORI) has outperformed its industry and peers over the past year, with its shares gaining 1.8% against an industry decline. The stock is currently trading at an attractive discount based on its price-to-book value and has a Value Score of A. Analysts project continued growth in earnings and revenues for 2026 and 2027, with an average target price suggesting a potential 7.8% upside.
Arthur J. Gallagher (AJG) Stock Trades Up, Here Is Why
Shares of Arthur J. Gallagher (AJG) rose 3.8% after the company announced the acquisition of International Insurance Brokers Pty Ltd, an Australian retail brokerage. This acquisition is expected to strengthen Arthur J. Gallagher's presence and retail brokerage capabilities in Australia, particularly in property coverage for non-profit organizations. Despite a year-to-date decline, long-term investors have seen significant returns.
Price to sales ratio of MetLife, Inc. – BSESOF:MWZ
This article provides a financial overview focusing on the price-to-sales ratio of MetLife, Inc. (BSESOF:MWZ). It mentions that the market is currently closed with no trades. The content primarily lists various data sources and disclaimers for the financial information provided.
